Cargando…
Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinases
Gain-of-function mutations in the genes encoding Janus kinases have been discovered in various haematologic diseases. Jaks are composed of a FERM domain, an SH2 domain, a pseudokinase domain and a kinase domain, and a complex interplay of the Jak domains is involved in regulation of catalytic activi...
Autores principales: | Haan, Claude, Behrmann, Iris, Haan, Serge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823453/ https://www.ncbi.nlm.nih.gov/pubmed/20132407 http://dx.doi.org/10.1111/j.1582-4934.2010.01018.x |
Ejemplares similares
-
Cooperative effects of Janus and Aurora kinase inhibition by CEP701 in cells expressing Jak2V617F
por: Gäbler, Karoline, et al.
Publicado: (2013) -
DFT study on the structural and chemical properties of Janus kinase inhibitor drug Baricitinib
por: Sonia, Chiging, et al.
Publicado: (2022) -
Molecular Structure and Function of Janus Kinases: Implications for the Development of Inhibitors
por: Garrido-Trigo, Alba, et al.
Publicado: (2020) -
JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms
por: Gäbler, Karoline, et al.
Publicado: (2013) -
Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells
por: Zimmer, Andreas David, et al.
Publicado: (2016)